Contract analysis
Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.
Contract analysis / draft-office-action-response-con2.docx
draft-office-action-response-con2.docx
High · 0
Medium · 3
Standard · 2
I. Preliminary Statement
Standard
⚑ Commercial term
I. Preliminary Statement Applicant, Solstice Biomedical Devices Ltd. ("Applicant"), by and through its undersigned attorney of record, Peter Vassiliev (Reg. No. 72,340), of Calderwood & Harkness LLP, hereby submits this Response to the Non-Final Office Action mailed by the United States Patent and Trademark Office ("USPTO") on September 15, 2024 (the "Office Action"), in connection with the above-identified applicati
II. Status of Claims
II. Status of Claims The following table summarizes the current status of all pending claims in this application: By this Response, Applicant amends Claims 1, 2, 4, 5, 7, 9, 10, 12, 13, 15, and 17. No claims are canceled. No new claims are added. Claims 1-20 are pending.
III. Amendments to the Claims
Standard
⚑ Commercial term
III. Amendments to the Claims Pursuant to 37 C.F.R. § 1.121, the listing of claims below replaces all prior versions of the claims. The text of amended claims is shown with additions underlined and deletions in strikethrough, in accordance with 37 C.F.R. § 1.121(c)(2). Claim 1 (Currently Amended): A cryoablation catheter system for performing tissue ablation with integrated impedance mapping, the system comprising: a
IV. Remarks
Medium
⚑ Notice / time limit to track
IV. Remarks A. Introduction and Overview Applicant respectfully submits the following Remarks in support of the amendments set forth above and in traversal of the rejections and objections set forth in the Office Action mailed September 15, 2024. Applicant believes that the amendments and arguments presented herein place all pending Claims 1-20 in condition for allowance, and respectfully requests the Examiner's favo
V. Conclusion
Medium
⚑ Notice / time limit to track
V. Conclusion In view of the foregoing amendments and Remarks, Applicant respectfully requests reconsideration and complete withdrawal of all rejections and objections set forth in the Office Action mailed September 15, 2024, including: (1) The rejection of Claims 1-8 under 35 U.S.C. § 103; (2) The rejection of Claims 9-14 under 35 U.S.C. § 112(a); and (3) The objection to Claims 15-20 as dependent on a rejected base
VI. Signature block
VI. Signature block Respectfully submitted, CALDERWOOD & HARKNESS LLP By: /Peter Vassiliev/ ________________________________________ Peter Vassiliev Registration No. 72,340 Date: ________ Calderwood & Harkness LLP 600 Lexington Avenue, 22nd Floor New York, NY 10022 Telephone: (212) 555-0147 Facsimile: (212) 555-0148
VII. Certificate of Service / Filing
Medium
⚑ Confidentiality undertaking
VII. Certificate of Service / Filing CERTIFICATE OF ELECTRONIC FILING I hereby certify that this Response to Non-Final Office Action, together with all concurrently filed documents identified in Appendix A hereto, is being filed electronically via the USPTO Patent Center on this date. /Peter Vassiliev/ ________________________________________ Peter Vassiliev Registration No. 72,340 Date: ________ Appendix A — Listing